Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
deals
life sciences
national blog main
national top stories
7
×
boston blog main
boston top stories
fda
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston
clinical trials
san diego blog main
san diego top stories
startups
alnylam pharmaceuticals
europe blog main
europe top stories
indiana blog main
indiana top stories
ipo
johnson & johnson
m&a
medical devices
new york
novartis
rna interference
sanofi
wisconsin blog main
wisconsin top stories
abbvie
acetylon pharmaceuticals
akouos
alex gorsky
alexion pharmaceuticals
alirocumab
allergan
alnylam pharmaceutials
What
deal
7
×
medicines
billion
startup
acquire
cash
fda
new
plans
rna
abandoning
acquiring
acquisitions
adding
ago
agreed
aiming
ambys
announced
approval
atrial
auris
baggage
betting
big
bio
biopharma
biotech
boston
brings
builds
business
buy
ceo
cholesterol
collabs
companies
company
company’s
compound
Language
unset
Current search:
deal
×
biotech
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion